Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$101.21 - $166.61 $809 - $1,332
8 Added 0.39%
2,045 $242,000
Q1 2024

Apr 30, 2024

SELL
$85.37 - $115.44 $2,219 - $3,001
-26 Reduced 1.26%
2,037 $217,000
Q4 2023

Feb 05, 2024

BUY
$69.51 - $104.43 $143,399 - $215,439
2,063 New
2,063 $205,000
Q1 2022

Apr 25, 2022

SELL
$126.46 - $235.05 $99,524 - $184,984
-787 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $21,452 - $35,008
95 Added 13.73%
787 $200,000
Q3 2021

Nov 05, 2021

BUY
$221.9 - $484.47 $153,554 - $335,253
692 New
692 $266,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Mission Wealth Management, LP Portfolio

Follow Mission Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.